Ex vivo engineered immune organoids for controlled germinal center reactions

被引:100
|
作者
Purwada, Alberto [1 ]
Jaiswal, Manish K. [2 ]
Ahn, Haelee [3 ]
Nojima, Takuya [4 ]
Kitamura, Daisuke [4 ]
Gaharwar, Akhilesh K. [2 ,5 ]
Cerchietti, Leandro [3 ]
Singh, Ankur [6 ]
机构
[1] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA
[2] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA
[3] Cornell Univ, Weill Cornell Med Coll, Div Hematol & Med Oncol, New York, NY USA
[4] Tokyo Univ Sci, Res Inst Biomed Sci, Div Mol Biol,Res, Noda, Chiba 2780022, Japan
[5] Texas A&M Univ, Dept Mat Sci & Engn, College Stn, TX 77843 USA
[6] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA
基金
美国国家卫生研究院;
关键词
B cell; Germinal center; Nanocomposite biomaterials; Immuno-engineering; Organoids; Class switching; FOLLICULAR DENDRITIC CELLS; CENTER B-CELLS; ANTIGEN-PRESENTING CELLS; IN-VITRO; INTEGRIN ALPHA-V-BETA-3; NANOCOMPOSITE HYDROGELS; CROSS-LINKING; BCL6; INHIBITOR; MECHANISM;
D O I
10.1016/j.biomaterials.2015.06.002
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Ex vivo engineered three-dimensional organotypic cultures have enabled the real-time study and control of biological functioning of mammalian tissues. Organs of broad interest where its architectural, cellular, and molecular complexity has prevented progress in ex vivo engineering are the secondary immune organs. Ex vivo immune organs can enable mechanistic understanding of the immune system and more importantly, accelerate the translation of immunotherapies as well as a deeper understanding of the mechanisms that lead to their malignant transformation into a variety of B and T cell malignancies. However, till date, no modular ex vivo immune organ has been developed with an ability to control the rate of immune reaction through tunable design parameter. Here we describe a B cell follicle organoid made of nanocomposite biomaterials, which recapitulates the anatomical microenvironment of a lymphoid tissue that provides the basis to induce an accelerated germinal center (GC) reaction by continuously providing extracellular matrix (ECM) and cell cell signals to naive B cells. Compared to existing co-cultures, immune organoids provide a control over primary B cell proliferation with similar to 100-fold higher and rapid differentiation to the GC phenotype with robust antibody class switching. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:24 / 34
页数:11
相关论文
共 50 条
  • [31] Immune responses to transgene and retroviral vector in patients treated with ex vivo engineered T-cells
    Lamers, C.
    van Elzakker, P.
    van Steenbergen, S.
    Oosterwijk, J.
    Sleijfer, S.
    Debets, R.
    Gratama, J.
    IMMUNOLOGY, 2012, 137 : 688 - 688
  • [32] Microvascular fluid flow in ex vivo and engineered lungs
    Raredon, Micha Sam Brickman
    Engler, Alexander J.
    Yuan, Yifan
    Greaney, Allison M.
    Niklason, Laura E.
    JOURNAL OF APPLIED PHYSIOLOGY, 2021, 131 (05) : 1444 - 1459
  • [33] CHACTERISATION OF BLADDER CANCER DRUG RESPONSES IN ORGANOIDS AND EX VIVO MODELS
    Kiener, Mirjam
    Karkampouna, Sofia
    La Manna, Federico
    De Menna, Marta
    Thalmann, George N.
    Seiler-Blarer, Roland
    Kruithof-de Julio, Marianna
    JOURNAL OF UROLOGY, 2020, 203 : E929 - E930
  • [34] Human pancreatic ductal organoids with controlled polarity provide a novel ex vivo tool to study epithelial cell physiology
    Varga, Arpad
    Madacsy, Tamara
    Gorog, Marietta
    Kiss, Aletta
    Susanszki, Petra
    Szabo, Viktoria
    Jojart, Boldizsar
    Dudas, Krisztina
    Farkas Jr, Gyula
    Szederkenyi, Edit
    Lazar, Gyorgy
    Farkas, Attila
    Ayaydin, Ferhan
    Pallagi, Petra
    Maleth, Jozsef
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (07)
  • [35] Human pancreatic ductal organoids with controlled polarity provide a novel ex vivo tool to study epithelial cell physiology
    Árpád Varga
    Tamara Madácsy
    Marietta Görög
    Aletta Kiss
    Petra Susánszki
    Viktória Szabó
    Boldizsár Jójárt
    Krisztina Dudás
    Gyula Farkas
    Edit Szederkényi
    György Lázár
    Attila Farkas
    Ferhan Ayaydin
    Petra Pallagi
    József Maléth
    Cellular and Molecular Life Sciences, 2023, 80
  • [36] Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection
    Miles, Brodie
    Miller, Shannon M.
    Folkvord, Joy M.
    Levy, David N.
    Rakasz, Eva G.
    Skinner, Pamela J.
    Connick, Elizabeth
    PLOS PATHOGENS, 2016, 12 (10)
  • [37] Lipid Membrane-Based Antigen Presentation to B Cells Using a Fully Synthetic Ex Vivo Germinal Center Model
    Kramer, Liana
    Song, Hannah W.
    Mitchell, Kaiya
    Kartik, Mythili
    Jain, Ritika
    Escarra, Victoria Lozano
    Quiros, Enrique
    Fu, Harrison
    Singh, Ankur
    Roy, Krishnendu
    ADVANCED NANOBIOMED RESEARCH, 2022, 2 (07):
  • [38] Efficient Immune Cell Editing with Engineered CRISPR-Cas12i for Ex Vivo Cell Therapy
    Sengupta, Sejuti
    Haswell, Jeffrey R.
    Keston-Smith, Elise
    Wessells, Quinton
    Garrity, Anthony J.
    Yan, Paul
    Jakimo, Noah
    Mcgaw, Colin
    Chong, Shaorong
    Scott, David A.
    DiTommaso, Tia
    MOLECULAR THERAPY, 2022, 30 (04) : 450 - 450
  • [39] The Role of In Vivo and Ex Vivo Diagnostic Tools in Severe Delayed Immune-Mediated Adverse Antibiotic Drug Reactions
    Copaescu, Ana
    Mouhtouris, Effie
    Vogrin, Sara
    James, Fiona
    Chua, Kyra Y. L.
    Holmes, Natasha E.
    Douglas, Abby
    Slavin, Monica A.
    Cleland, Heather
    Zubrinich, Celia
    Aung, Ar Kar
    Goh, Michelle S. Y.
    Phillips, Elizabeth J.
    Trubiano, Jason A.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (05): : 2010 - +
  • [40] Invoking immune resistance in acute myeloid leukemia (AML) cells through ex-vivo allogeneic immune reactions
    Parveen, Mubaida
    Esendagli, Gunes
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 262 - 262